StephenGDiversMD

PubMed

• 15 citations
  Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
  Ray D. Page, Leylah Drusbosky, Hiba I. Dada, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona-Calero, Daniel Dix, Justin ...> ;Clinical Lung Cancer. 2021 Oct 10
• 330 citations
  Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.
  Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona-Calero, Daniel Dix, Justin I. Odegaard, ...> ;Clinical Cancer Research. 2019 Apr 15
• 492 citations
  Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
  Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill, Dragan Sebisanovic, Rene Lopez, Sibel Blau, Eric A. Collisson, Stephen G. Divers, Dave S.B. Hoon, E. Scott Kopetz...> ;Plos One. 2015 Oct 16
• 12 citations
  Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.
  Phuong Khanh Morrow, Stephen Divers, Louise Provencher, Shiuh Wen Luoh, Teresa M. Petrella, Marius Giurescu, Thomas Schmelter, Yao Wang, Gabriel N. Hortobagyi, Linda T...> ;Breast Cancer Research and Treatment. 2010 Aug 10
• Phase II study of sagopilone (ZK-Epo) in patients with recurrent metastatic breast cancer (MBC).
  Morrow PH, Divers SG, Provencher L, Luoh S, Petrella TM, Giurescu M, Fielding L, Wang Y, Hortobagyi GN, Vahdat LT> ;J. Clin. Oncol.. 2009-05-20
• 10 citations
  Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced ...
  Stephen G. Divers, Sharon A. Spencer, Delicia Carey, Elizabeth M. Busby, Mark D. Hyatt, Francisco Robert> ;Journal of Clinical Oncology. 2005 Sep 20
• 8 citations
  Acute transient leukopenia as a sign of TRALI.
  Marisa B. Marques, Hande H. Tuncer, Stephen G. Divers, Allyson C. Baker, D. Keith Harrison> ;American Journal of Hematology. 2005 Sep 1
• 19 citations
  Scurvy: an often forgotten cause of bleeding.
  Regina de Luna, B. Judson Colley, Kathleen J. Smith, Stephen G. Divers, John J. Rinehart, Marisa B. Marques> ;American Journal of Hematology. 2003 Sep 1
• 194 citations
  Informed Consent for Clinical Trials: a Comparative Study of Standard Versus Simplified Forms
  Terry C. Davis, Randall F. Holcombe, Hans Berkel, Sumona Pramanik, Stephen G. Divers> ;Journal of the National Cancer Institute. 1998 May 6
• Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy.
  Kannan, K., Divers, S. G., Lurie, A. A., Chervenak, R., Fukuda, M., Holcombe, R. F.> ;Eur J Haematol. 1995 Sep
• Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates.
  Divers, S. G., Kannan, K., Stewart, R. M., Betzing, K. W., Dempsey, D., Fukuda, M., Chervenak, R., Holcombe, R. F.> ;Transfusion. 1995 Apr
• Join now to see all